Article
MedImpact, a leading pharmacy benefit manager, will contribute the "Drug Trends" column for AJPB.
FOR IMMEDIATE RELEASE JANUARY 21, 2014
American Journal of Pharmacy Benefits Collaborates With MedImpact to Publish Drug Trends
PLAINSBORO, N.J. — The American Journal of Pharmacy Benefits, a peer-reviewed publication under The American Journal of Managed Care network, today announced an editorial collaborates with MedImpact Healthcare Systems, Inc. to provide the journal’s “Drug Trends” column six times a year.
MedImpact is the largest full-service pharmacy benefit manager (PBM) that derives revenue by managing the drug benefit, not from dispensing drugs. MedImpact partners with health plans, hospitals and employers to provide PBM services to more than 47 million members in the United States. It serves all market segments: commercial, Medicare, Medicaid, self-insured employers, state and local governments, 340B, and discount loyalty cards.
“Through this editorial partnership, readers of The American Journal of Pharmacy Benefits will gain insights from experts who handle pharmacy needs for millions of Americans, from all walks of life,” said Brian Haug, publisher of AJPB. “We expect strong response from our readers, and we look forward to bringing them this feature with every issue.”
Bimal V. Patel, PharmD, MS, who serves as director, Health Outcomes, will direct the project for MedImpact. “We always look for ways to share what we learn from serving so many customers, and we expect this collaboration to provide feedback for us as well,” Patel said. “We are excited The American Journal of Pharmacy Benefits has given us this opportunity to address what is happening in healthcare delivery. Given our focus on the patient as a whole, we plan to introduce quality trends as an additional focus to the Drug Trend’s column.”
The first MedImpact contribution to “Drug Trends,” on changes in medication adherence by market segment, will appear in the January/February issue of AJPB. It will feature observations about medications that treat three common conditions: diabetes, hypertension and cholesterol.
CONTACT: Nicole Beagin, Associate Editorial Director
(609) 716-7777 x 131
About MedImpact Healthcare Systems, Inc.
MedImpact Healthcare Systems, Inc. (http://www.medimpact.com), founded in 1989 and headquartered in San Diego, CA, is a PBM that combines subject matter expertise with innovative technology and services to deliver better health care outcomes and improve its clients’ positions in the market. MedImpact provides PBM services to 47 million members of health plans, hospitals and employers in the U.S. and abroad. MedImpact’s model is unique: avoiding conflict of interest by not owning mail order or specialty pharmacies and instead deriving revenue from effectively managing client pharmacy benefits. MedImpact’s results are quantified through detailed peer analysis, demonstrating how the company can help its clients be market leaders rather than followers.
Media Contact:
Gordon Romanas, Vice President of Marketing
MedImpact Healthcare Systems, Inc.
Tel: 858.790.6475
Email: gordon.romanas@medimpact.com
How Can Employers Leverage the DPP to Improve Diabetes Rates?